News | May 05, 2026
Silent cough, deadly risk: Doctors warn of hidden asthma surge amid rising pollution
Marking World Asthma Day 2026, doctors sounded the alarm over a steady surge in respiratory illnesses
Marking World Asthma Day 2026, doctors sounded the alarm over a steady surge in respiratory illnesses
Founded by Amit Patni, the company rolls out 90+ formulations across acute and specialty therapies
At launch of updated pediatric gastroenterology textbook, Union Minister says technology must strengthen not substitute core medical learning
The drug meets all primary endpoints across 608 patients in Europe and India, strengthening the company's biosimilars pipeline
The Flonase Allergy Relief Nasal Spray, 50 mcg per spray market achieved annual sales of approximately $384.7 million
The oral therapy is aimed at adults with chronic spontaneous urticaria (CSU) who do not respond adequately to H1-antihistamines
The board highlighted ongoing investments in Radiopharma, CDMO Sterile Injectables, and CRDMO businesses
Nucala is the first and only monthly biologic in the EU evaluated in a wide COPD population with an eosinophilic phenotype
The approval for Exdensur (depemokimab-ulaa) comes on the back of SWIFT-1 and SWIFT-2 Phase III trials
It's a development that marks a major step forward for patients struggling with moderate-to-severe chronic spontaneous urticaria
Subscribe To Our Newsletter & Stay Updated
